Biosurgical Agents – Market Insights – Europe (Supplemental)

The European biosurgical agent market was negatively impacted by the COVID-19 pandemic. However, increasing procedure volume along with rising awareness of the clinical benefits of biosurgical agents in surgical procedures and expanded indications in multiple procedures will drive modest growth in the market.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for biosurgical agents in Europe including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2031.